Metastatic
Showing 26 - 50 of >10,000
Discovering Factors in Metastatic Breast Cancer Patients'
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Feb 25, 2023
Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- (no location specified)
Jun 15, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 1, 2023
Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational
Not yet recruiting
- Metastatic Cancers
- Fatigue
- Psychoeducational Intervention
- +2 more
-
Houston, TexasMD Anderson Cancer Centerr
Oct 10, 2023
PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)
Not yet recruiting
- PROSTATE CANCER
- +2 more
- Supervised Circuit Training
-
Boston, Massachusetts
- +2 more
Sep 13, 2023
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jun 27, 2023
Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)
Not yet recruiting
- Metastatic Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 7, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Nov 13, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Metastatic Urothelial Carcinoma Trial in Guangzhou (utidelone injection)
Recruiting
- Metastatic Urothelial Carcinoma
- utidelone injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
May 29, 2023
Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)
Not yet recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX treatment
- (no location specified)
Aug 9, 2023
Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)
Not yet recruiting
- Metastatic Microsatellite-stable Colorectal Cancer
- (no location specified)
Sep 1, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)
Not yet recruiting
- Metastatic Colorectal Cancer
- Liposomal irinotecan
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
May 2, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,
Not yet recruiting
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 18, 2023
Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Bicalutamide 150 mg
- Placebo
-
Québec, CanadaCHU de Québec - Université Laval
Sep 6, 2023
Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)
Recruiting
- Advanced or Metastatic Solid Tumor
- KRAS G12C Mutation
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Nov 2, 2023
Metastatic Pathologic Fractures, Short Term Results
Recruiting
- Pathologic Fracture
- +2 more
- endoprosthetic reconstruction
- +2 more
-
Ankara, Altindag, TurkeyAnkara University Medical Faculty
Apr 11, 2023
Trifluridine/Tipiracil Plus Bevacizumab Versus
Completed
- Metastatic Colorectal Adenocarcinoma
-
Changsha, Hunan, ChinaHunan Cancer hospital
May 11, 2023
Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023